Sanofi to Invest €1.3 Billion in New Insulin Manufacturing Plant in Frankfurt, Germany

French pharmaceutical giant Sanofi announced on the 1st that it will build a new, modern insulin production plant at its biotechnology campus in Frankfurt-Höchst. The project, which is expected to be completed by 2029, represents an investment of approximately 1.3 billion euros.

 

According to reports, Sanofi currently operates an insulin production plant in Hoechst. The new production plant, covering an area of approximately 36,000 square meters, will replace the existing production plant. By 2029, it is expected that hundreds of highly qualified professionals will be working at the new plant. The project has received support from the German federal government, the Hesse state government, and the Frankfurt municipal government, and still requires approval from the European Commission.

 

Heidrun Irschik-Hadjieff, head of Sanofi Germany, stated that the investment plan highlights the crucial role played by Frankfurt's biotechnology park in enhancing the resilience of global insulin production. The federal and state governments havePharmaceuticalsStrong strategic support is an important signal for the biopharmaceuticals industry.

 

German media reports pointed out that, with the advancement of Sanofi's investment plan, pharmaceutical companies' investments in Germany have further increased. Previously, the U.S. pharmaceutical company Eli Lilly planned to invest 2.3 billion euros to build a high-tech production base in Germany. Japanese pharmaceutical company Daiichi Sankyo and Swiss pharmaceutical giant Roche also announced multi-billion euro investments.

 

Robert Hermann, Managing Director of Germany Trade & Invest, told reporters that Sanofi's investment plan reflects Germany's past and future strength in the pharmaceutical sector. The German government regards the pharmaceutical industry as an economic pillar for the coming years, and its implemented incentive measures and reforms are encouraging global pharmaceutical giants to have confidence in Germany.